MedTrace Logo

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

NCT05960201 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-08-21

No results posted yet for this study

Summary

This study aims to explore the diagnostic validity of \[18F\]FES PET/CT for the evaluation of axillary lymph node metastasis in patients with invasive lobular breast cancer having clinically suspected or confirmed axillary lymph node metastasis.

Conditions

  • Carcinoma, Lobular

Interventions

DRUG

[18F]fluoroestradiol (FES)

F-18 FES 111\~222 MBq(megabecquerel) injection

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Sangwon Han · Clinical assistant professor

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2024-08-20
Completion
2024-08-20

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05960201 on ClinicalTrials.gov